secwatch.observer — SEC 8-K summary
======================================

Issuer:     Picard Medical, Inc. (PMI)
CIK:        0002030617
Form:       8-K
Filed at:   2026-05-29T11:05:27+00:00
Accession:  0001829126-26-005779
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Picard Medical Q1 revenue up 85%, gross margin 24%; NYSE listing notice received
--------------------------------------------------------------------------------

- Q1 2026 revenue $1.2M (+85% YoY); gross profit margin 24% vs. -58% in Q1 2025.
- 2025 total revenue $4.9M (+12.5%); IPO raised $17.4M net; year-end cash $11.5M.
- Repaid $7.4M senior debt in Q1; post-quarter public offering raised $5.0M gross.
- Next-gen Emperor TAH second-gen animal testing completed May 2026; FDA submission target 2028.
- NYSE American notified of stockholders' equity deficiency; compliance plan due June 7, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626005779/0001829126-26-005779-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2030617/000182912626005779/picardmedical_8k.htm
  HTML page:      https://secwatch.observer/filing/0001829126-26-005779

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer